↓ Skip to main content

CD20-specific antibody-targeted chemotherapy of non-Hodgkin’s B-cell lymphoma using calicheamicin-conjugated rituximab

Overview of attention for article published in Cancer Immunology, Immunotherapy, December 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent
16 patents

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
33 Mendeley
Title
CD20-specific antibody-targeted chemotherapy of non-Hodgkin’s B-cell lymphoma using calicheamicin-conjugated rituximab
Published in
Cancer Immunology, Immunotherapy, December 2006
DOI 10.1007/s00262-006-0260-5
Pubmed ID
Authors

John F. DiJoseph, Maureen M. Dougher, Douglas C. Armellino, Lyka Kalyandrug, Arthur Kunz, Erwin R. Boghaert, Philip R. Hamann, Nitin K. Damle

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
France 1 3%
Unknown 31 94%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 27%
Researcher 7 21%
Student > Master 4 12%
Student > Bachelor 3 9%
Professor > Associate Professor 2 6%
Other 4 12%
Unknown 4 12%
Readers by discipline Count As %
Chemistry 9 27%
Agricultural and Biological Sciences 6 18%
Biochemistry, Genetics and Molecular Biology 5 15%
Immunology and Microbiology 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 3 9%
Unknown 7 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 October 2022.
All research outputs
#3,799,858
of 25,377,790 outputs
Outputs from Cancer Immunology, Immunotherapy
#273
of 2,982 outputs
Outputs of similar age
#13,761
of 167,895 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#5
of 23 outputs
Altmetric has tracked 25,377,790 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,982 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 167,895 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 23 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.